A detailed history of Graham Capital Management, L.P. transactions in Pulmonx Corp stock. As of the latest transaction made, Graham Capital Management, L.P. holds 32,708 shares of LUNG stock, worth $246,945. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,708
Previous 18,994 72.2%
Holding current value
$246,945
Previous $176,000 17.61%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.77 - $9.82 $79,129 - $134,671
13,714 Added 72.2%
32,708 $207,000
Q1 2024

May 15, 2024

BUY
$8.71 - $14.65 $165,437 - $278,262
18,994 New
18,994 $176,000
Q3 2023

Nov 22, 2023

SELL
$9.88 - $14.0 $13,673 - $19,376
-1,384 Reduced 12.05%
10,101 $104,000
Q2 2023

Aug 14, 2023

BUY
$10.78 - $13.65 $123,808 - $156,770
11,485 New
11,485 $150,000
Q2 2022

Aug 15, 2022

BUY
$14.0 - $27.95 $266,532 - $532,112
19,038 New
19,038 $280,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $281M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.